Genie AI Health Screening: Fraudulent AI Cancer Early Screening Franchise Scam, Leaving Franchisees Penniless

Who Gets Targeted

The primary victims are small and medium-sized investors and individual business owners with some savings who are seeking low-threshold, high-return projects, commonly found in third- and fourth-tier cities and counties. Most lack a background in the medical industry or basic knowledge of clinical validation. They often have a vague sense of trust in AI technology and are easily swayed by pitches about 'blue ocean' health markets or exclusive regional agencies. Their psychological vulnerability lies in the desire for stable income coupled with the fear of missing out on a trend, combined with a moral alignment with the altruistic aura of cancer screening. They often neglect to verify qualifications or the actual efficacy of the equipment, rushing to sign contracts and pay fees under the high-pressure atmosphere of investment seminars.

骗局怎么运作

• Fabricated Brands and Medical Endorsements: Scammers register or impersonate tech-sounding names like Genie AI, forging cooperation agreements, clinical reports, and expert recommendation videos from well-known hospitals, universities, or overseas laboratories. They advertise through investment websites and short-video platforms, claiming the equipment uses 'quantum resonance + AI deep learning' for non-invasive early screening of multiple cancers.
• Free Experience Funnels and False Positive Intimidation: They attract middle-aged and elderly people under the guise of community health initiatives or free cancer screenings. The equipment is actually a modified ordinary bio-electric or infrared detector. The backend allows manual adjustment of indicators, intentionally issuing high-risk reports to some participants to create panic and induce them to purchase expensive follow-up tests or treatment packages.
• Brainwashing Seminars and Scarcity Marketing: They organize offline investment seminars or online live streams, arranging for 'successful' franchisees to share testimonials of earning hundreds of thousands in monthly revenue. They claim only 3 regional spots remain, offering equipment discounts and headquarters traffic support for on-site sign-ups, creating a sense of urgency to pressure franchisees into paying immediately.
• Collecting High Franchise Fees and Equipment Deposits: Franchisees are required to pay tens to hundreds of thousands of yuan in brand authorization fees, equipment deposits, and initial supply costs. Contract terms are vague, and the equipment delivered is often a 'three-no' product (no manufacturer, no date, no quality certificate) or a basic physiotherapy device, lacking any medical device registration certificate or AI screening functionality.
• Post-Sale Disappearance and Secondary Exploitation: After opening, franchisees find the equipment fails health department inspections and consumer complaints mount. The headquarters deflects responsibility, citing improper operation or the need for system upgrades, then demands additional fees for 'AI algorithm upgrades' or 'exclusive supply procurement.' Eventually, customer service goes silent, offices are vacated, and franchisees are left with nothing.

红旗信号（看到这些快跑）

• 🚩 Claims of AI-based non-invasive cancer screening with 5-minute reports, but unable to provide a National Medical Products Administration (NMPA) medical device registration certificate or clinical validation data.
• 🚩 Short company registration history, no physical office address, or frequent changes in the investment entity's name or affiliation with overseas shell companies.
• 🚩 Collecting personal information under the guise of free experiences or public welfare screenings, and conducting tests in non-medical venues such as beauty salons, wellness centers, or community activity rooms.
• 🚩 Promises of exclusive regional agencies, headquarters traffic support, or guaranteed return on investment, emphasizing limited spots and time-sensitive discounts to pressure immediate payment.
• 🚩 Vague contract terms, lack of refund mechanisms, and requirements for separate, overpriced procurement of equipment and supplies.

真实案例

• According to search results, no public reports currently identify a cancer screening franchise scam explicitly named 'Genie AI,' but similar fraudulent AI medical investment models have appeared in multiple regions.
• There have been reports from India of a woman who paid 20,000 rupees for an AI cancer screening, only to receive a false-positive report for pancreatic cancer. This caused severe anxiety and nearly led to unnecessary treatment; doctors have publicly warned that unvalidated AI screening can be misleading.
• Xinhua News Agency exposed a health and wellness center scam in Hunan and other areas, where gangs used colon-cleansing fluid mixed with soy sauce to fake detoxification effects, specifically targeting the elderly by fabricating health risks. The case involved massive sums, and multiple individuals were arrested by the police.

Official Stance

• 2026 National Health Commission Alert: Non-medical institutions such as beauty salons and wellness centers are prohibited from conducting medical activities like stem cell therapy or cancer screening. It is strictly forbidden to exaggerate efficacy or hype concepts like 'curing chronic diseases.' Clues should be reported to public security, health, or market regulation departments.
• 2026 State Administration for Market Regulation Crackdown: AI virtual influencer live streams promoting false health food claims and conference marketing fabricating 'cures' for chronic conditions are key targets. AI-based medical advertising fraud is explicitly classified as illegal.
• The National Anti-Fraud Center, in collaboration with the Ministry of Public Security, launched an AI anti-fraud application in 2026. It features one-click identification of scam patterns and typical cases, reminding the public to remain vigilant against new scams involving AI medical testing and franchise investments.

How to Protect Yourself

• ✅ Verify Medical Device Qualifications: Require the investment party to present the medical device registration certificate, production license, and clinical evaluation report issued by the NMPA. Any AI cancer screening device must be included in the medical device management catalog.
• ✅ Check Company Background: Use the National Enterprise Credit Information Publicity System to check the company's establishment date, paid-in capital, business anomalies, and administrative penalty records. Be wary of shell companies where the registered address differs from the actual operating address. Cross-reference the medical device registration number on the NMPA official website; if they don't match, walk away.
• ✅ Reject Screenings at Non-Medical Institutions: Cancer screenings should be conducted at formal hospitals or designated medical insurance institutions. Refuse any 'free AI testing' conducted in non-medical venues like beauty salons, wellness centers, or community rooms.
• ✅ Do Not Trust Investment Promises Easily: Be skeptical of high-return promises like exclusive regional agencies, guaranteed returns, or headquarters traffic support. Consult a professional lawyer to review contracts before signing, ensuring refund and exit mechanisms are clearly defined.
• ✅ Retain Evidence and Report Promptly: Save promotional materials, chat logs, transfer receipts, and contracts. If anomalies are found, report immediately to 12315, health departments, or public security organs to avoid secondary transfers or additional investments.